Włochy - włoski - AIFA (Agenzia Italiana del Farmaco)

3m deutschland gmbh - articaina, associazioni - articaina, associazioni

Włochy - włoski - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - lormetazepam - lormetazepam

Włochy - włoski - AIFA (Agenzia Italiana del Farmaco)

fidia farmaceutici s.p.a. - zolpidem - zolpidem

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - cochlearia officinalis (hab) d5, echinacea (hab) d5, euphrasia (hab) d5, pilocarpus (hab) d5 - collirio monodosen - cochlearia officinalis (hab) d5 246 mg, echinacea (hab) d5 246 mg, euphrasia (hab) d5 246 mg, pilocarpus (hab) d5 246 mg, natrii chloridum, natrii dihydrogenophosphas dihydricus 2.06 mg, dinatrii phosphas dihydricus 9.35 mg, aqua ad iniectabile, ad solutionem pro 1.0 ml. - gemäss homöopathischem arzneimittelbild bei reizzuständen wie leichten entzündungen der augen, überanstrengten augen, tränenden augen, sandgefühl in den augen und lichtempfindlichkeit - farmaci omeopatici

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

armeeapotheke - diazepamum - auto-iniettore - diazepamum 10 mg, propylenglycolum, ethanolum 175.4 mg, acidum benzoicum 7.5 mg, natrii benzoas 91.14 mg, alcohol benzylicus 33.86 mg, aqua ad iniectabile q.s. ad solutionem pro 2 ml. - di emergenza e di krampfzuständen, che lotta nervengiften essere causato. - antidota

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

t&s eye care management ag - belladonna (ph.eur.hom.) d6, euphrasia officinalis d6, hepar sulfuris (hab) d12 - collirio 10 ml - belladonna (ph.eur.hom.) d6 303.33 ml, euphrasia officinalis d6 303.33 mg, hepar sulfuris (hab) d12 303.33 mg, argenti sulfas, excipiens ad solutionem pro 1 g. - gemäss homöopathischem arzneimittelbild bei leichten formen von entzündeten, geröteten augen, lidrandentzündungen, brennenden augen und lichtempfindlichkeit. - farmaci omeopatici

Unia Europejska - włoski - EMA (European Medicines Agency)

amicus therapeutics europe limited - cipaglucosidase alfa - glicogen storage disease type ii - altro apparato digerente e metabolismo prodotti, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Unia Europejska - włoski - EMA (European Medicines Agency)

amicus therapeutics europe limited - miglustat - glicogen storage disease type ii - altri prodotti per il tratto alimentare e il metabolismo - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).